Functionalized Spiky Microcarriers Orchestrate STING Activation and Durable Antitumor Immunity
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Liru Shang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou510080, China. Hauptthemen laut MEDLINE: Membrane Proteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
The stimulator of interferon (IFN) genes (STING) pathway has garnered considerable attention due to its significant potential in anti-cancer effect. However, cyclic dinucleotides (CDNs), which are natural agonists or their derivatives for STING, are often hindered by their inherent properties of poor transmembrane permeability and potential systemic toxicity. Herein, we employed polyethylenimine (PEI)-functionalized spiky TiO2 microparticles (SP-PEI) for the efficient delivery of CDNs into antigen-presenting cells (APCs). This delivery system leverages the electrostatic interaction between PEI and CDNs, allowing for the absorption of CDNs onto the spiky microparticle (SP) structure. Furthermore, the optimized microstructure of SP-PEI facilitates preferential phagocytosis by APCs, thereby enabling effective intracellular delivery of CDNs. Our findings demonstrated that SP-PEI significantly promoted CDNs phagocytosis by dendritic cells (DCs), leading to robust activation of the STING pathway and subsequent induction of type I interferons, which in turn fostered DC maturation. Furthermore, in MC38 tumor models, SP-PEI-CDN was observed to significantly delay the progression of both primary and distant tumors. Finally, the co-administration of SP-PEI-CDN with the chemotherapeutic agent doxorubicin (DOX) achieved excellent therapeutic efficacy against melanoma in both primary and distant tumor sites, underscoring the broad effectiveness of our delivery strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou510080, China.
- State Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-Sen University, Guangzho…
- Department of General Dentistry II, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of…
ORCID-Profile: Xi Xie, Hui-Jiuan Chen, Ji Wang, Xiafeng Wang
Förderung
- National Natural Science Foundation of China (NSFC)
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Shang, L., Peng, L., Huang, Z., Deng, C., Jiang, J., Xie, X., Chen, H. J., Wang, Y., Wang, J., & Wang, X. (2026). Functionalized Spiky Microcarriers Orchestrate STING Activation and Durable Antitumor Immunity. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01695
Vancouver
Shang L, Peng L, Huang Z, Deng C, Jiang J, Xie X, et al. Functionalized Spiky Microcarriers Orchestrate STING Activation and Durable Antitumor Immunity. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01695
BibTeX
@article{Shang2026,
author = {Shang, Liru and Peng, Lin and Huang, Zhangping and Deng, Caiguanxi and Jiang, Juan and Xie, Xi and Chen, Hui-Jiuan and Wang, Yuguang and Wang, Ji and Wang, Xiafeng},
title = {Functionalized Spiky Microcarriers Orchestrate STING Activation and Durable Antitumor Immunity},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01695}
}
EUVIMED